Study on Imagery Rescripting vs Exposure for OCD by King's College London
A study is underway to compare the effectiveness of imagery rescripting versus exposure therapy for OCD.
Published: July 27, 2026
Updated: July 27, 2026
Author: Humanexa Intelligence
Therapeutic area: Psychiatry / OCD
Asset: Study
Trial SummaryCLN
Phase III
Psychiatry / OCD
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Signalhigh
Confidencemoderate
Why it matters
The ongoing trial comparing imagery rescripting and exposure therapy for OCD could reshape treatment paradigms in psychiatry. Outcomes may influence product development and market positioning for existing therapies targeting OCD.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and publication of findings to assess the impact on OCD treatment paradigms.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.